Loading interface...

Vocarb 0.2 MG Tablet

Manufactured byGlenmark Pharmaceuticals Ltd.
ContainsVoglibose
Description
Vocarb 0.2 MG Tablet is used to lower blood glucose levels in patients with Type 2 Diabetes Mellitus, especially when other medicines are not able to provide the desired results. It belongs to a group of medicines known as alpha-glucosidase inhibitors.

Side effects

Major & minor side effects for Vocarb 0.2 MG Tablet

  • Diarrhea
  • Flatulence
  • Pneumatosis Intestinalis
  • Abnormal liver function
  • Nausea or vomiting
  • Dizziness

Uses of Vocarb 0.2 MG Tablet

What is it prescribed for?

  • Type II Diabetes Mellitus
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendency has been reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe an alternative medicine based on your clinical condition.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe an alternative medicine based on your clinical condition.

Allergy

This medicine is not recommended for patients having a known history of allergy to voglibose or any other inactive ingredients present in the formulation.

Intestinal obstruction

This medicine is not recommended for use in patients having intestinal obstruction due to the increased risk of worsening of the patient's condition.

Digestive disorders

This medicine is not recommended for use in patients having long-term digestive disorders due to the increased risk of conditions like Gastroesophageal reflux disorder, Inflammatory bowel disorder, heartburn, etc.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe an alternative medicine based on your clinical condition.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe an alternative medicine based on your clinical condition.
General warnings

Use in children

This medicine is not recommended for use in children since the safety and efficacy of use are not clinically established.

Liver disease

This medicine should be used with extreme caution in patients with liver diseases due to the increased risk of worsening of the patient's condition. Regular monitoring of liver function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Kidney disease

This medicine should be used with caution in patients with kidney diseases due to the increased risk of adverse effects. Regular monitoring of kidney function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Gastrointestinal diseases

This medicine is not recommended for use in patients with any gastrointestinal diseases like inflammatory bowel disease, colonic ulceration, partial intestinal obstruction, or any chronic intestinal disease. It is advised that you should inform the doctor about all your medical conditions before starting treatment with this medicine.

Missed Dose

Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Insulin

Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine exactly as prescribed by the doctor. It is advised to take this medicine just before meals. Your dose is likely to change over time based on therapeutic response and clinical condition. Regular monitoring of blood sugar levels is recommended during treatment with this medicine. You should always carry a sugar candy with you to counteract unexpected lowering of blood sugar levels. Do not change the dose or duration of use without consulting your doctor.
Miscelleneous

To be taken before food

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine works by reducing the blood glucose level by preventing the breakdown of large carbohydrates into glucose. This helps in reducing the glucose levels in the blood after food.
Legal Status

Approved

Unknown

Approved

Unknown

Classification

Category

Alpha-glucosidase inhibitors

Schedule

Schedule H

voglibose | C10H21NO7 - PubChem [Internet]. Pubchem.ncbi.nlm.nih.gov. 2017 [cited 7 March 2017]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/444020#section=Top

[Internet]. 2017 [cited 23 October 2017]. Available from:

http://www.stridesarco.com/pdf/Branded/india/cardiac_care/glybose_03.pdf
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 6 Mar 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.